hbe

M2N12 is a potent and highly selective inhibitor of cell division cycle 25C protein phosphatase (Cdc25C, IC50 = 0.09 μM) and also exhibits anti-tumor activity. Additionally, M2N12 shows promising activity against Cdc25A (IC50 = 0.53 μM) and Cdc25B (IC50 = 1.39 μM).

HBED (CHELII) is an iron chelator and can be used in research on the treatment of chronic iron overload and acute iron poisoning.

dA-NHbenzylOCF3 is a DNA-targeting radiosensitizer that enhances tumor cell sensitivity to X-rays via the dissociative electron attachment (DEA) mechanism. It exhibits low toxicity to normal cells and primarily localizes in the cytoplasm and nucleus after cellular entry. The compound induces radiosensitization by causing cell cycle arrest at the G2/M phase, which is sensitive to radiation. dA-NHbenzylOCF3 is applicable in research on radiosensitization for malignant tumors such as prostate and breast cancer.

PROTACHBeAg degrader-1 is a PROTAC-based targeted degrader of HBeAg. It effectively recruits the VHL E3 ligase, yet its ability to degrade the hepatitis B virus protein (HBeAg) does not depend on VHL recruitment. This compound decreases levels of both secreted and intracellular HBeAg and is suitable for research involving the hepatitis B virus (HBV).

HBeAg ligand 1 (Compound S2) is an HBeAg inhibitor utilized in the synthesis of PROTAC HBeAg degrader-1.

HBED-CC-tris(tert-butyl ester) is a monovalent variant of HBED-CC, utilized in the synthesis of synthetic radiocompounds based on asymmetric HBED-CC for tumor imaging.

GV-150013X ((S)-1-(1-(adamantan-1-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)-3-phenylurea) is a potent CCKB antiagonist, pKi= 9.02.

(-)-OPC-51803 is an antidiuretic hormone V2 receptor agonist used in the treatment of nocturia and urinary incontinence.

BDCRB inhibits herpesvirus DNA maturation. BDCRB causes the HCMV terminase to skip the normal cleavage site and to continue to package DNA until a second cleavage site is encountered 30 kb further along the concatemer.

(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.

dCeMM3 (2-(1H-benzimidazol-2-ylsulfanyl)-N-(5-chloropyridin-2-yl)acetamide) is a glue degrader. dCeMM3 prompts an interaction of CDK12-cyclin K with a CRL4B ligase complex, result in inducing ubiquitination and degradation of cyclin K.

Benzoquinamide hydrochloride (3-carbamoyl-N,N-diethyl-1,3,4,6,7,11b-hexahydro-9,11-dimethoxy-2H-benzo[a]quinolizin-2-yl acetate hydrochloride) is an antiemetic agent and increases intra-arterial pressure due to the increased peripheral vascular resistance.

Sodium Oxamate (Oxamic acid sodium salt) is an LDH inhibitor that specifically inhibits LDHA. Sodium Oxamate has antitumor activity and induces cell cycle arrest and apoptosis.

1H-Benzotriazole ,with CAS No. 95-14-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 1H-Benzotriazole provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

1,3-Dihydro-1-(1,2,3,6-tetrahydro-4-pyridinyl)-2H-benzimidazole-2-one ,with CAS No. 2147-83-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 1,3-Dihydro-1-(1,2,3,6-tetrahydro-4-pyridinyl)-2H-benzimidazole-2-one provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Doxofylline (Doxophylline) is a methylxanthine derivative with the presence of a dioxolane group in position 7. As a drug used in the treatment of asthma, doxofylline has shown similar efficacy to theophylline but with significantly fewer side effects in animal and human studies.

Kanamycin sulfate (Kanamycin monosulfate) is an aminoglycoside antibiotic that interferes with protein synthesis by binding to the 70S ribosomal subunit of bacteria. Kanamycin sulfate exhibits antimicrobial activity against both Gram-positive and Gram-negative bacteria, as well as mycoplasmas.

Beclometasone dipropionate (Vancenase) is the dipropionate ester of a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. After cell surface receptor attachment and cell entry, beclomethasone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.

Emamectin Benzoate (MK-244), by binding gamma-aminobutyric acid (GABA) receptor and glutamate-gated chloride channels disrupting nerve signals within arthropods, acts as a chloride channel activator.

Ensulizole is a sulfonated ultraviolet absorber that strongly absorbs UVB and some UVA, and under UV or sunlight exposure, it produces reactive oxygen species that can damage DNA.

5,6-Dimethyl-1H-benzo[d]imidazole (5,6-Dimethylbenzimidazole) is an intermediate in Riboflavin metabolism and is the penultimate step in the synthesis of alpha-Ribazole. It is converted from Riboflavin and subsequently transformed into N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole by the enzyme nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (EC 2.4.2.21).

2-Pentyl-1H-benzo[d]imidazole is a micromolar level inhibitor of Cytochrome P450 1A1 and 2B1 and has antibacterial activity against Fusarium verticillioides.

4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid ,with CAS No. 152628-03-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

1H-Benzimidazole-2-methanamine, 6-chloro-, dihydrochloride, with CAS No. 1185297-00-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 1H-Benzimidazole-2-methanamine, 6-chloro-, dihydrochloride provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.